Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Por Escudier, Bernard, Cosaert, Jan, Jethwa, Sangeeta
Publicado em 2008

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Por Gerber, David E., Swanson, Paul, Lopez-Chavez, Ariel, Wong, Lucas, Dowlati, Afshin, Pennell, Nathan A., Cronier, Damien M., Qin, Amy, Ilaria, Robert, Cosaert, Jan, Shahir, Ashwin, Baggstrom, Maria Q.
Publicado no Lung Cancer (2017)

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

Por LoRusso, Patricia M., Gounder, Mrinal, Jalal, Shadia I., André, Valérie, Kambhampati, Siva Rama Prasad, Loizos, Nick, Hall, Jennifer, Holzer, Timothy R., Nasir, Aejaz, Cosaert, Jan, Kauh, John, Chiorean, E. Gabriela
Publicado no Invest New Drugs (2017)

A Phase 1 Study of Anti-TGFβ Receptor Type-II Monoclonal Antibody LY3022859 in Patients with Advanced Solid Tumors

Por Tolcher, Anthony W., Berlin, Jordan D., Cosaert, Jan, Kauh, John, Chan, Emily, Piha-Paul, Sarina A., Amaya, Alex, Tang, Shande, Driscoll, Kyla, Kimbung, Richard, Prasad Kambhampati, S. R., Gueorguieva, Ivelina, Hong, David S.
Publicado no Cancer Chemother Pharmacol (2017)

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

Por Gradishar, William J., Yardley, Denise A., Layman, Rachel, Sparano, Joseph A., Chuang, Ellen, Northfelt, Donald W., Schwartz, Gary N., Youssoufian, Hagop, Tang, Shande, Novosiadly, Ruslan, Forest, Amelie, Nguyen, Tuan S., Cosaert, Jan, Grebennik, Dmitri, Haluska, Paul
Publicado no Clin Cancer Res (2015)

An Open-label, Dose-Escalation Phase 1 Study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma

Por Khalil, Danny N., Postow, Michael A., Ibrahim, Nageatte, Ludwig, Dale L., Cosaert, Jan, Kambhampati, Siva Rama Prasad, Tang, Shande, Grebennik, Dmitri, Kauh, John Sae Wook, Lenz, Heinz-Josef, Flaherty, Keith T., Hodi, F. Stephen, Lawrence, Donald P., Wolchok, Jedd D.
Publicado no Clin Cancer Res (2016)

Olaratumab and doxorubicin versus doxorubicin alone in soft tissue sarcoma

Por Tap, William D., Jones, Robin L., Van Tine, Brian A., Chmielowski, Bartosz, Elias, Anthony D., Adkins, Douglas, Agulnik, Mark, Cooney, Matthew M., Livingston, Michael B., Pennock, Gregory, Hameed, Meera R., Shah, Gaurav D., Qin, Amy, Shahir, Ashwin, Cronier, Damien M., Ilaria, Robert, Conti, Ilaria, Cosaert, Jan, Schwartz, Gary K.
Publicado no Lancet (2016)